Some of you may remember that small trials of Ecopipam, a D1 antagonist were carried out by William Ondo inTexas in 2019 and showed encouraging initial results in treating Augmentation on Dopamine Agonists.
Dr Stefan Clements at East Carolina University then applied for a patent to use Ecopipam for Augmentation caused by dopamine agonists. This was granted and Emalex biosciences has now been given a manufacturing licence.
There have been larger studies taking place so hopefully we will hear the results soon.
If Ecopipam can successfully dampen the D1 receptors that cause Augmentation, that would give hope to hundreds of thousands of RLS patients taking dopamine agonists.
I thought it was/is only about making money. Over our 'heads'. A small study, far from conclusive and they apply for a patent. Patents should be stopped completely. Most often the largest part of the research behind a med is done by researchers at universities and the like (read: paid by governments = tax money). Only the final studies to get the medicines accepted for a special purpose / treatment is done by pharmaceutical companies. No wonder they are over-the-top rich.
I was appalled when I read about the patent and wondered why rls.org made such a big thing of it.
Incredible news! Thanks for sharing! I have my appointment with Dr Buchfuhrer in 2 weeks and am going to ask him his thoughts on the matter. Really exciting stuff!
I'm cautiously optimistic. I don't know if Dr Clemens has added something or adjusted the dose but if it works to stop augmentation it would be fantastic. Fingers 🤞
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
Too Much D1...anyone? The untold (?) story behind augmentation
Can augmentation be avoided on DA's?
